Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection

ConditionLiver
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

To learn if an accelerated recovery program can shorten the length of hospital stay in patients having minimally invasive liver surgery.

Eligibility criteria

Qualifiers

Tumor amenable to MIS Kawaguchi-Gayet grade I hepatectomy (see figure 1 below)

No evidence of cirrhosis (based on imaging, evidence of portal hypertension, clinical features, or laboratory results)

No significant cardiopulmonary disease that would prevent patients from undergoing MIS resection

Ability to stay within 50 miles of medical center for immediate postop period

Disqualifiers

Tumors NOT amenable to MIS Kawaguchi-Gayet grade I hepatectomy

Tumors not amenable to MIS or Robotic-assisted surgical resection

Evidence of Cirrhosis on imaging, clinically, or lab testing

Inability to stay within 50 miles of the Cancer Center in the immediate post-operative period

Trial design

Treatments tested in this trial

  • Questionnaires

Treatment groups

36 Participants
are divided into 2 treatment groups

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

Intuitive Surgical

Collaborator